Guardant Health, Inc.
(NASDAQ : GH)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
LHCGLHC Group, Inc. 0.15%166.473.0%$94.04m
GHGuardant Health, Inc. 10.97%42.740.0%$94.03m
DNAGinkgo Bioworks Holdings, Inc. 7.26%3.180.0%$75.23m
DVADaVita, Inc. -0.06%97.384.1%$73.87m
NTRANatera, Inc. 5.34%41.211.1%$64.55m
AZTAAzenta, Inc. 5.43%77.260.0%$48.70m
ACHCAcadia Healthcare Co., Inc. -0.26%71.7326.6%$45.75m
NUTXNutex Health, Inc. 0.71%9.980.0%$45.66m
AGLAgilon Health, Inc. 3.75%19.940.0%$42.20m
AMEDAmedisys, Inc. -0.62%116.6611.4%$40.07m
OSHOak Street Health, Inc. 6.63%19.460.0%$37.41m
NVTAInvitae Corp. 15.00%4.031.1%$37.36m
TVTYTivity Health, Inc. 0.09%32.348.8%$30.69m
OPCHOption Care Health, Inc. 5.61%30.700.0%$27.19m
ONEM1Life Healthcare, Inc. 4.66%8.870.0%$24.03m

Company Profile

Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2012 and is headquartered in Palo Alto, CA.